5th Floor, Building D, 3-1 Zhongdan Unit, South Longshan Rd, Jiangbei New District, Nanjing, Jiangsu, China 210061
With its cutting-edge technologies and robust antibody discovery platform, Biosion is committed to discover and develop world-class antibody drugs for the unmet medical needs.
Biosion "SynNovation 100 program" with the goal to develop first-in-class or best-in-class antibody drug candidates to 100 critically reviewed drug targets.
Leveraging its proprietary H³ antibody platform and SynAb™ technology, Biosion is committed to develop antibody drug candidates with optimal specificity and mechanistic drug properties.
Biosion is a biotech company focusing on the discovery and preclinical development of innovative biologicals for unmet medical needs.